Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

hylan G-F 20

hylan G-F 20
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Synvisc SOLUTION, INTRA-ARTICULAR 16 mg/2 mL    
Synvisc One SOLUTION, INTRA-ARTICULAR 48 mg/6 mL      
VIEW MORE Skin and Mucous Membrane Agents, Miscellaneous
CLASS
849200
Comments:

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

hylan G-F 20 (Synvisc)

  • 16 mg/2 mL

sodium hyaluronate (Supartz)

  • 10 mg/mL

Synvisc is non-formulary. The formulary hyaluronic acid products are Supartz and Euflexxa.

Synvisc One is approved for formulary use in the hospital outpatient setting. It should not be administered in the inpatient setting.

Reviewed: September 26, 2006 and April 26, 2011 (Synvisc One)

Last updated: Dec. 21, 2017






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved